Hyperactivity News and Research

RSS

Largest study ever to look at possible heart risks with ADHD medications

Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive study to date of prescription medications used to treat attention deficit hyperactivity disorder (ADHD) and the potential for increased risk of heart attack, stroke or other cardiovascular problems.

18 Sep 2007

New discovery for Fragile X Syndrome

An important finding has been made by McMaster researchers about Fragile X Syndrome (FXS), a sex-linked genetic disorder that affects approximately one in 4,000 males and one in 6,000 females.

11 Sep 2007

Pennsylvania gets to grips with Fetal Alcohol Spectrum Disorder

Health officials in Pennsylvania in the U.S. are calling for more awareness of Fetal Alcohol Spectrum Disorder (FASD).

11 Sep 2007

New understanding of role of schizophrenia risk gene DISC1 in normal adult brains

How the gene that has been pegged as a major risk factor for schizophrenia and other mood disorders that affect millions of Americans contributes to these diseases remains unclear.

10 Sep 2007

Link shown between ADHD, food colourings and additives

Suspicions about a link between food colourings and additives and hyperactivity have been established as a fact by British researchers.

9 Sep 2007

ADHD and preschoolers

Attention-deficit/hyperactivity disorder (ADHD) is no longer diagnosed just in schoolchildren.

5 Sep 2007

Bipolar disorder a growing health issue

The estimated number of youth with office visits with a diagnosis of bipolar disorder substantially increased between 1994 and 2003, while adult visits with a bipolar disorder diagnoses appeared to almost double, according to a report in the September issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

4 Sep 2007

8.7 percent of US children age 8 to 15 meet criteria for having ADHD

An estimated 8.7 percent of U.S. children age 8 to 15 meet diagnostic criteria for attention-deficit/hyperactivity disorder, but fewer than half receive treatment, according to a report in the September issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

4 Sep 2007

Urgent need for better understanding of bipolar disease in children and adolescents

The number of visits to a doctor's office that resulted in a diagnosis of bipolar disorder in children and adolescents has increased by 40 times over the last decade, reported researchers funded in part by the National Institutes of Health (NIH).

4 Sep 2007

Detailed picture of prevalence of ADHD in U.S.

Most children in the United States who meet the medically accepted definition of Attention Deficit Hyperactivity Disorder (ADHD) have not been diagnosed by a physician, and are not consistently treated with medications, according to the first national ADHD prevalence study in children based on the "gold standard" of diagnostic criteria, according to a new study conducted by researchers at Cincinnati Children's Hospital Medical Center.

4 Sep 2007

Children just beginning school need their sleep

The first investigation of developmental sleep duration patterns throughout childhood shows that children just beginning school and who get little sleep are more likely to have behavioral and cognitive problems in the classroom, according to a study published in the September 1 issue of the journal SLEEP.

3 Sep 2007

Risperdal approved for psychiatric conditions in children and adolescents

The U.S. Food and Drug Administration has approved Risperdal (risperidone) for the treatment of schizophrenia in adolescents, ages 13 to 17, and for the short-term treatment of manic or mixed episodes of bipolar I disorder in children and adolescents ages 10 to 17.

24 Aug 2007

Restless legs syndrome common and troublesome in children and adolescents

Restless legs syndrome is a common problem in children 8 years of age and older in the United States and the United Kingdom, according to a new report from an international team of researchers.

24 Aug 2007

Antipsychotic drug Risperdal approved for use in children

The Food and Drug Administration (FDA) in the U.S. has given approval for the antipsychotic drug Risperdal to be used to treat schizophrenia and bipolar disorder in children and teenagers.

23 Aug 2007

Non-medicinal interventions for young children with ADHD

Non-medicinal interventions are highly effective in preventing the behavioral and academic problems associated with Attention Deficit Hyperactivity Disorder (ADHD), according to a five-year study led by researchers at Lehigh University's College of Education.

22 Aug 2007

Study looks at father's role in a household with a depressed mother

Children whose mothers are depressed are less likely to develop problem behaviors if their fathers are actively engaged in family life, a Saint Louis University researcher finds.

16 Aug 2007

Variant of the dopamine receptor gene may be associated with ADHD

A variant of the dopamine receptor gene may be associated with attention-deficit/hyperactivity disorder (ADHD) and with thinner tissue in areas of the brain that handle attention, but also appears associated with better clinical outcomes among individuals with the disorder, according to a report in the August issue of Archives of General Psychiatry , one of the JAMA/Archives journals.

7 Aug 2007

Brain areas that control attention thinnest in children with ADHD

Brain areas that control attention were thinnest in children with attention deficit hyperactivity disorder (ADHD) who carried a particular version of a gene in a study by the National Institutes of Health's (NIH) National Institute of Mental Health (NIMH).

7 Aug 2007

ADHD linked to depressed dopamine activity in the brain

Adults with attention-deficit/hyperactivity disorder (ADHD) show a blunted response to the drug methylphenidate (Ritalin), which increases brain dopamine levels, according to a report in the August issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

7 Aug 2007

Methylphenidate improves vigilance performance of ADHD children with poor sleep

WESTCHESTER, Ill. -- In the first known study of its kind, an article published in the August 1st issue of the journal SLEEP finds that children with attention deficit hyperactivity disorder (ADHD), and whose sleep efficiency is poor, experience significant improvement on some measures of the Continuous Performance Test (CPT) if they are treated with methylphenidate (MPH).

2 Aug 2007